| scholarly article | Q13442814 |
| P356 | DOI | 10.1021/ACS.JMEDCHEM.5B01474 |
| P698 | PubMed publication ID | 27046062 |
| P50 | author | Jenny Desantis | Q86820506 |
| Laura Goracci | Q41571112 | ||
| P2093 | author name string | Oriana Tabarrini | |
| Serena Massari | |||
| P2860 | cites work | Identification of influenza virus inhibitors which disrupt of viral polymerase protein-protein interactions | Q45363861 |
| A common reference framework for analyzing/comparing proteins and ligands. Fingerprints for Ligands and Proteins (FLAP): theory and application. | Q51919227 | ||
| Evaluating the risk of phospholipidosis using a new multidisciplinary pipeline approach | Q59489001 | ||
| Ligand-, structure- and pharmacophore-based molecular fingerprints: a case study on adenosine A1, A2A, A2B, and A3 receptor antagonists | Q59489014 | ||
| Clinical Implications of Antiviral Resistance in Influenza | Q26782746 | ||
| Neuraminidase inhibitors for influenza B virus infection: efficacy and resistance | Q27021579 | ||
| Crystal structure of the RNA-dependent RNA polymerase from influenza C virus | Q27315161 | ||
| Spatial dynamics of human-origin H1 influenza A virus in North American swine | Q27349761 | ||
| Crystal structure of the polymerase PA(C)-PB1(N) complex from an avian influenza H5N1 virus | Q27651109 | ||
| The structural basis for an essential subunit interaction in influenza virus RNA polymerase | Q27651365 | ||
| Structure and inhibition of the drug-resistant S31N mutant of the M2 ion channel of influenza A virus | Q27675846 | ||
| Discovery of epigenetic regulator I-BET762: lead optimization to afford a clinical candidate inhibitor of the BET bromodomains | Q27685477 | ||
| Structural insight into cap-snatching and RNA synthesis by influenza polymerase | Q27696194 | ||
| LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions | Q27861128 | ||
| Functional analysis of PA binding by influenza a virus PB1: effects on polymerase activity and viral infectivity | Q27863706 | ||
| Identification of two separate domains in the influenza virus PB1 protein involved in the interaction with the PB2 and PA subunits: a model for the viral RNA polymerase structure. | Q27867695 | ||
| New small-molecule drug design strategies for fighting resistant influenza A | Q28080554 | ||
| The RNA synthesis machinery of negative-stranded RNA viruses | Q28084418 | ||
| Drug-Like Protein-Protein Interaction Modulators: Challenges and Opportunities for Drug Discovery and Chemical Biology | Q42701435 | ||
| Emerging influenza antiviral resistance threats | Q42725866 | ||
| Molecular basis of the interaction for an essential subunit PA-PB1 in influenza virus RNA polymerase: insights from molecular dynamics simulation and free energy calculation | Q43250372 | ||
| Global assessment of resistance to neuraminidase inhibitors, 2008-2011: the Influenza Resistance Information Study (IRIS). | Q44805348 | ||
| Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States | Q45118572 | ||
| A peptide derived from the C-terminus of PB1 inhibits influenza virus replication by interfering with viral polymerase assembly | Q45353251 | ||
| Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication | Q28476315 | ||
| Identification of high-affinity PB1-derived peptides with enhanced affinity to the PA protein of influenza A virus polymerase | Q28743238 | ||
| Reaching for high-hanging fruit in drug discovery at protein-protein interfaces | Q29547258 | ||
| Improved protein-ligand docking using GOLD | Q29616787 | ||
| Small-molecule inhibitors of protein-protein interactions: progressing towards the dream | Q29617758 | ||
| Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic | Q29619055 | ||
| Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans | Q29619059 | ||
| Human infection with a novel avian-origin influenza A (H7N9) virus | Q29620049 | ||
| Avian influenza A H5N1 virus: a continuous threat to humans | Q30224462 | ||
| Origin and molecular characterization of the human-infecting H6N1 influenza virus in Taiwan | Q30354679 | ||
| Clinical and epidemiological characteristics of a fatal case of avian influenza A H10N8 virus infection: a descriptive study. | Q30358802 | ||
| Antiviral combinations for severe influenza. | Q30366719 | ||
| Emerging antiviral targets for influenza A virus. | Q30376907 | ||
| Large-scale sequence analysis of M gene of influenza A viruses from different species: mechanisms for emergence and spread of amantadine resistance. | Q30379476 | ||
| Potential targets and their relevant inhibitors in anti-influenza fields. | Q30380593 | ||
| Complete-proteome mapping of human influenza A adaptive mutations: implications for human transmissibility of zoonotic strains. | Q30385456 | ||
| Peramivir: an intravenous neuraminidase inhibitor for the treatment of 2009 H1N1 influenza | Q30389887 | ||
| Influenza virus evolution, host adaptation, and pandemic formation | Q30390262 | ||
| Generation and characterization of recombinant pandemic influenza A(H1N1) viruses resistant to neuraminidase inhibitors | Q30397253 | ||
| Comprehensive assessment of 2009 pandemic influenza A (H1N1) virus drug susceptibility in vitro | Q30397287 | ||
| Laninamivir octanoate: a new long-acting neuraminidase inhibitor for the treatment of influenza | Q30407794 | ||
| Structure-based discovery of anti-influenza virus A compounds among medicines | Q30409850 | ||
| Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives | Q30410899 | ||
| Small molecule inhibitors of influenza A and B viruses that act by disrupting subunit interactions of the viral polymerase | Q30414976 | ||
| Influenza antiviral resistance in the Asia-Pacific region during 2011 | Q30425223 | ||
| Influenza virus resistance to neuraminidase inhibitors. | Q30428660 | ||
| Susceptibility of highly pathogenic A(H5N1) avian influenza viruses to the neuraminidase inhibitors and adamantanes. | Q33263979 | ||
| Preclinical profile of BI 224436, a novel HIV-1 non-catalytic-site integrase inhibitor | Q33797858 | ||
| Small-molecule inhibitors of protein-protein interactions: progressing toward the reality | Q34263719 | ||
| Emerging antiviral resistant strains of influenza A and the potential therapeutic targets within the viral ribonucleoprotein (vRNP) complex | Q34269400 | ||
| Drug susceptibility surveillance of influenza viruses circulating in the United States in 2011-2012: application of the WHO antiviral working group criteria | Q34292717 | ||
| Epidemiology of human infections with avian influenza A(H7N9) virus in China. | Q34341070 | ||
| Favipiravir (T-705), a novel viral RNA polymerase inhibitor | Q34374652 | ||
| Emergence of influenza B viruses with reduced sensitivity to neuraminidase inhibitors | Q34615286 | ||
| Disruption of the viral polymerase complex assembly as a novel approach to attenuate influenza A virus | Q34624418 | ||
| Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide | Q34637724 | ||
| Global transmission of oseltamivir-resistant influenza | Q34955928 | ||
| Seasonal influenza vaccines | Q35004203 | ||
| New prospects for the rational design of antivirals | Q35011532 | ||
| The fight against the influenza A virus H1N1: synthesis, molecular modeling, and biological evaluation of benzofurazan derivatives as viral RNA polymerase inhibitors. | Q35055899 | ||
| Structure-based design of small-molecule protein-protein interaction modulators: the story so far. | Q35103944 | ||
| Adamantane-resistant influenza a viruses in the world (1902-2013): frequency and distribution of M2 gene mutations | Q35175284 | ||
| Pharmacophore-based discovery of inhibitors of a novel drug/proton antiporter in human brain endothelial hCMEC/D3 cell line | Q36211219 | ||
| Flexibility and small pockets at protein-protein interfaces: New insights into druggability. | Q36501662 | ||
| An overlapping protein-coding region in influenza A virus segment 3 modulates the host response | Q36554219 | ||
| The origin and global emergence of adamantane resistant A/H3N2 influenza viruses | Q37250829 | ||
| A complicated message: Identification of a novel PB1-related protein translated from influenza A virus segment 2 mRNA. | Q37275127 | ||
| Influenza A(H7N9) virus gains neuraminidase inhibitor resistance without loss of in vivo virulence or transmissibility. | Q37394266 | ||
| Three-dimensional pharmacophore methods in drug discovery | Q37615315 | ||
| Towards an atomic resolution understanding of the influenza virus replication machinery | Q37671352 | ||
| The influenza virus RNA synthesis machine: advances in its structure and function | Q37847896 | ||
| Nucleoproteins and nucleocapsids of negative-strand RNA viruses | Q37913694 | ||
| The RNA polymerase of influenza a virus: mechanisms of viral transcription and replication | Q38100247 | ||
| Viral RNA polymerase: a promising antiviral target for influenza A virus | Q38127807 | ||
| Inhibitors of protein-protein interactions: new methodologies to tackle this challenge | Q38180877 | ||
| Antiviral strategies against influenza virus: towards new therapeutic approaches | Q38202012 | ||
| The epidemiology and spread of drug resistant human influenza viruses | Q38215346 | ||
| At the centre: influenza A virus ribonucleoproteins | Q38270617 | ||
| Limited compatibility of polymerase subunit interactions in influenza A and B viruses | Q39719150 | ||
| High prevalence of amantadine resistance among circulating European porcine influenza A viruses | Q39882839 | ||
| Fine mapping of the subunit binding sites of influenza virus RNA polymerase | Q40732397 | ||
| 4,6-Diphenylpyridines as Promising Novel Anti-Influenza Agents Targeting the PA-PB1 Protein-Protein Interaction: Structure-Activity Relationships Exploration with the Aid of Molecular Modeling | Q40774044 | ||
| An RNA Hybridization Assay for Screening Influenza A Virus Polymerase Inhibitors Using the Entire Ribonucleoprotein Complex | Q40955312 | ||
| Molecular assembly of the influenza virus RNA polymerase: determination of the subunit-subunit contact sites | Q41171919 | ||
| Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2013-2014. | Q41344703 | ||
| Human cytomegalovirus inhibitor AL18 also possesses activity against influenza A and B viruses | Q41571076 | ||
| Peptide-mediated interference with influenza A virus polymerase | Q42124512 | ||
| A Broad Anti-influenza Hybrid Small Molecule That Potently Disrupts the Interaction of Polymerase Acidic Protein-Basic Protein 1 (PA-PB1) Subunits | Q42149862 | ||
| Structure of influenza A polymerase bound to the viral RNA promoter | Q42181164 | ||
| Optimization of small-molecule inhibitors of influenza virus polymerase: from thiophene-3-carboxamide to polyamido scaffolds | Q42221157 | ||
| High-throughput docking for the identification of new influenza A virus polymerase inhibitors targeting the PA-PB1 protein-protein interaction. | Q42250560 | ||
| Structural investigation of cycloheptathiophene-3-carboxamide derivatives targeting influenza virus polymerase assembly | Q42250689 | ||
| Influenza virus transcription and replication. | Q42257057 | ||
| Discovery and synthesis of novel benzofurazan derivatives as inhibitors of influenza A virus | Q42271617 | ||
| Comparison of the three large polymerase proteins of influenza A, B, and C viruses | Q42646848 | ||
| GRID-based three-dimensional pharmacophores I: FLAPpharm, a novel approach for pharmacophore elucidation | Q42667683 | ||
| P433 | issue | 17 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | protein-protein interaction | Q896177 |
| P304 | page(s) | 7699-7718 | |
| P577 | publication date | 2016-04-19 | |
| P1433 | published in | Journal of Medicinal Chemistry | Q900316 |
| P1476 | title | Polymerase Acidic Protein-Basic Protein 1 (PA-PB1) Protein-Protein Interaction as a Target for Next-Generation Anti-influenza Therapeutics | |
| P478 | volume | 59 |
| Q93155577 | A Parallel Phenotypic Versus Target-Based Screening Strategy for RNA-Dependent RNA Polymerase Inhibitors of the Influenza A Virus |
| Q91499929 | Design, Synthesis, and Biological Evaluation of Itaconic Acid Derivatives as Potential Anti-Influenza Agents |
| Q92470479 | Discovery of novel anti-influenza agents via contemporary medicinal chemistry strategies (2014-2018 update) |
| Q40043829 | Efficient and regioselective one-step synthesis of 7-aryl-5-methyl- and 5-aryl-7-methyl-2-amino-[1,2,4]triazolo[1,5-a]pyrimidine derivatives |
| Q51783651 | Exploring Ugi-Azide Four-Component Reaction Products for Broad-Spectrum Influenza Antivirals with a High Genetic Barrier to Drug Resistance. |
| Q40139477 | Exploring the cycloheptathiophene-3-carboxamide scaffold to disrupt the interactions of the influenza polymerase subunits and obtain potent anti-influenza activity |
| Q59357432 | Focusing on the influenza virus polymerase complex: recent progress in drug discovery and assay development |
| Q58539497 | From cycloheptathiophene-3-carboxamide to oxazinone-based derivatives as allosteric HIV-1 ribonuclease H inhibitors |
| Q37714501 | H9N2 Avian Influenza Virus Protein PB1 Enhances the Immune Responses of Bone Marrow-Derived Dendritic Cells by Down-Regulating miR375. |
| Q90808102 | Host-Virus Interaction: How Host Cells Defend against Influenza A Virus Infection |
| Q36191196 | Identification of a novel small-molecule compound targeting the influenza A virus polymerase PB1-PB2 interface. |
| Q47552890 | Influenza A virus polymerase: an attractive target for next-generation anti-influenza therapeutics |
| Q100521820 | Inhibition of Influenza Virus Polymerase by Interfering with Its Protein-Protein Interactions |
| Q47550666 | Inhibitors of Influenza A Virus Polymerase |
| Q92674012 | Insights into RNA-dependent RNA Polymerase Inhibitors as Anti-influenza Virus Agents |
| Q90280016 | Investigational antiviral therapies for the treatment of influenza |
| Q91455016 | Novel influenza inhibitors designed to target PB1 interactions with host importin RanBP5 |
| Q92457318 | Potent and broad-spectrum cycloheptathiophene-3-carboxamide compounds that target the PA-PB1 interaction of influenza virus RNA polymerase and possess a high barrier to drug resistance |
| Q97599917 | Redox control in the pathophysiology of influenza virus infection |
| Q100433077 | Searching for effective antiviral small molecules against influenza A virus: A patent review |
| Q101469873 | Structural characterization of the interaction between the C-terminal domain of the influenza polymerase PA subunit and an optimized small peptide inhibitor |
| Q39099407 | Structural insights into RNA synthesis by the influenza virus transcription-replication machine |
| Q59353957 | Synthesis and biological evaluation of a library of hybrid derivatives as inhibitors of influenza virus PA-PB1 interaction |
| Q104485956 | Synthesis and characterization of 1,2,4-triazolo[1,5-a]pyrimidine-2-carboxamide-based compounds targeting the PA-PB1 interface of influenza A virus polymerase |
| Q28071809 | The Influenza Virus Polymerase Complex: An Update on Its Structure, Functions, and Significance for Antiviral Drug Design |
Search more.